Community syndromes, endocarditis and sepsis
Start from the syndrome and threatened physiology
Respiratory, neurological, abdominal, urinary, skin and bloodstream presentations require different diagnostic and treatment pathways. Age, immune state, exposures, preceding antibiotics and local resistance change the differential. Collect appropriate specimens promptly when feasible, but do not delay urgent treatment in shock or another time-critical presentation solely to complete a convenient diagnostic sequence. A syndrome label is not a substitute for reassessing breathing, circulation, mental state and evolving organ dysfunction.
Pneumonia and central nervous system disease
Community pneumonia treatment depends on severity, comorbidity and resistance risks rather than an identical regimen for every outpatient and intensive-care patient. A severity score can support assessment but does not replace clinical judgment or supply every admission criterion. A pathogen-associated clue such as diarrhea with a particular pneumonia can be helpful without being pathognomonic. Bacterial meningitis requires appropriate early treatment and age- and host-specific coverage. Suspected encephalitis can require a different immediate antiviral pathway. The interpretation of CSF glucose, cells and protein is probabilistic, and a normal or partially treated profile does not exclude every serious infection.
Endovascular and deep infection
Endocarditis assessment integrates microbiology, imaging, cardiac findings and relevant risk context. A criterion classified as major is not the same as a complete definite diagnosis in every case. Apply the named criteria edition and do not reintroduce a removed mandatory timing condition. Prosthetic material, embolic complications, persistent bacteremia and valve dysfunction affect management. Acute severe regurgitation with shock requires a different urgency from stable culture follow-up. Deep abscesses, necrotizing infection and an obstructed infected biliary or urinary system can need source control as well as an active drug.
Host response and ongoing decisions
Sepsis concerns infection-related organ dysfunction, while shock has an additional circulatory and metabolic framework. The volume and rate of fluids depend on perfusion, response, tolerance and the actual situation rather than a rigid number divorced from assessment. Vasopressors, antimicrobial treatment and source control have complementary roles. Biomarkers may contribute to reassessment but should not automatically overrule a convincing urgent presentation or determine the entire treatment duration. Clinical improvement can support narrower or oral treatment when absorption, stability and the infection site permit. New deterioration requires reconsideration of the source, organism, exposure, complications and alternative diagnoses.